Match Document Document Title
US20150190361 COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES IN A SUBJECT ON CONCOMITANT STATIN THERAPY  
In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof.
US20130243851 EXTRUSION ENCAPSULATION OF ACTIVES AT AN INCREASED LOAD, USING SURFACE ACTIVE PLANT  
A glassy extrusion encapsulation composition and a method of making the composition are provided. The encapsulation composition comprises an encapsulate encapsulated in a glassy matrix comprising...
US20120128770 TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE  
The present invention relates to 1 or 2 C16-C18 acyl glycerol based compounds which are capable of activating G-protein coupled receptor 119 and thereby stimulate GLP-1 release. Compounds of the...
US20070003613 Preparations to support maintenance of acid-alkaline balance in the human body and methods directed to using same  
The present invention provides novel compositions in the form of a powder, capsule, liquid or lozenge, and methods for administering said novel compositions to assist the body in its ability to...
US20150150818 METHOD AND COMPOSITION OF GLYCOSAMINOGLYCANS IN SICKLE CELL AND VASCULAR DISORDERS  
A composition that includes a nanoparticle. The nanoparticle includes a shell which encapsulates sulfated non-anticoagulant heparin (SNACH). The shell includes poly L-arginine. The SNACH is...
US20130337059 Oral Pharmaceutical Dosage Forms  
Abuse-resistant oral dosage forms suitable for administration of pharmacologically active agents are provided.
US20150174114 METHODS FOR THE TREATMENT OF NON-HODGKIN'S LYMPHOMAS USING LENALIDOMIDE, AND GENE AND PROTEIN BIOMARKERS AS A PREDICTOR  
Methods of treating or managing specific cancers, including non-Hodgkin's lymphoma, by the administration of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-d ione are disclosed....
US20150250756 METHODS OF TREATING HYPERCHOLESTEROLEMIA  
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of treating hypercholesterolemia,...
US20110300212 Pharmaceutical Formulation  
The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a...
US20070298096 Analgesic/Antipyretic Compositions for Enhanced Absorption  
The onset of activity of a first analgesic/antipyretic composition containing an analgesic/antipyretic effective amount of acetaminophen, caffeine and, optionally, aspirin is shortened by...
US20150118293 NOVEL DELIVERY SYSTEM FOR ANTICANCER DRUG BASED ON SHORT-CHAIN- LENGTH POLYHYDROXYALKANOATE NANOPARTICLES  
The invention relates to the fabrication of novel and improved delivery system comprising of short-chain-length polyhydroxyalkanoates (scl-PHA) nanoparticles having anticancer drug ellipticine...
US20140255477 Compositions and Methods for Delivery of High-Affinity Oxygen Binding Agents to Tumors  
While tumor hypoxia is recognized as a key barrier to effective chemo and radiation therapy of solid tumor malignancies, and an important biological mediator of more aggressive tumor phenotype and...
US20130177641 COMPOSITIONS AND METHODS FOR DELIVERY OF HIGH-AFFINITY OXYGEN BINDING AGENTS TO TUMORS  
While tumor hypoxia is recognized as a key barrier to effective chemo and radiation therapy of solid tumor malignancies, and an important biological mediator of more aggressive tumor phenotype and...
US20110086094 CAPSULE FOR THE PREVENTION OF CARDIOVASCULAR DISEASES  
The invention relates to a capsule for the prevention of cardiovascular diseases which comprises coated tablets of acetylsalicylic acid, coated tablets of simvastatin or pravastatin, and coated...
US20130202696 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20110064797 CAPSULE OF THERMOGENIC CELLS FOR TREATING A METABOLIC DISEASE  
Described herein are methods and devices for treating a metabolic disease that involve implanting a micro-device into a tissue of a subject having a metabolic disease. The micro-device includes a...
US20110244033 TAMSULOSIN PELLETS FOR FIXED DOSE COMBINATION  
The invention relates to a population of tamsulosin-comprising pellets for oral administration of a combination dosage form containing physically separated a tamsulosin dose in the form of the...
US20150044284 DOSAGE FORM COMPRISING A STEROID 5-ALPHA-REDUCTASE INHIBITOR AND AN ALPHA BLOCKER, PROCESS FOR PREPARING OF A DOSAGE FORM, USE OF DOSAGE FORM, METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A DISEASE OR CONDITION MEDIATED BY ANDROGEN  
The present invention describes new and improved dosage forms containing a steroid 5-alpha-reductase inhibitor, in combination with an alpha blocker, for the treatment or prophylaxis of an...
US20130337053 NOVEL FORMULATIONS AND METHODS  
A formulation comprising T3/VIP nanoparticles, wherein the T3/VIP nanoparticle comprises both T3 and VIP encapsulated or immobilized on a bioabsorbable polymer. The invention further provides for...
US20140186436 ORAL DELIVERY OF ENZYMES BY NANOCAPSULES FOR TARGETED METABOLISM OF ALCOHOL OR TOXIC METABOLITES  
The invention disclosed herein includes nanocomplexes that are designed include enzymes that have complementary functional attributes and methods for using these nanocomplexes. Illustrative...
US20120301544 PHARMACEUTICAL FORMULATIONS OF LORATADINE FOR ENCAPSULATION AND COMBINATIONS THEREOF  
This invention relates to a loratadine formulation suitable for encapsulation into a soft gel capsule or suitable dosage unit improved functionality providing enhanced in vitro dissolution and...
US20130302409 METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY  
The present invention generally relates to the field of cancer and methods and compositions for cancer immunotherapy. In one embodiment, a method for treating cancer in a patient comprises the...
US20140341984 TAMPER RESISTANT PHARMACEUTICAL FORMULATIONS  
Disclosed in certain embodiments is an oral dosage form comprising a plurality of particles, each particle comprising a compressed core comprising: (i) an active agent susceptible to abuse and...
US20140271776 Preparations Derived From Placental Materials and Methods of Making and Using Same  
Preparations derived from placental materials and methods of making and using same, the preparations including a first preparation composed of placental membranes digested in collagenase, a second...
US20120201875 STABLE LOW DIGESTIVE ENZYME CONTENT FORMULATION  
The present invention is directed to a pharmaceutical composition or dosage form having a stable, low (diluted) digestive enzyme content comprising at least one digestive enzyme and at least one...
US20130089603 COMPOSITIONS AND METHODS FOR TREATING OBESITY AND OBESITY-RELATED CONDITIONS  
A method to effectively treat the adverse events of ingested lipase inhibitor such as orlistat, and to maintain the effectiveness of ingested orlistat, the method comprising the steps of:...
US20140134238 TANNIN-CHITOSAN COMPOSITES  
The invention provides a composition comprising a matrix of chitosan and a tannin wherein the chitosan is electrostatically bonded to the tannin to form a chitosan-tannin composite material. The...
US20110059162 TANNIN-CHITOSAN COMPOSITES  
The invention provides a composition comprising a matrix of chitosan and a tannin wherein the chitosan is electrostatically bonded to the tannin to form a chitosan-tannin composite material. The...
US20130017254 PHARMACEUTICAL FORMULATION CONTAINING PHENYTOIN SODIUM AND MAGNESIUM STEARATE  
The present invention relates to a novel pharmaceutical formulation comprising phenytoin sodium, a high amount of magnesium stearate, and a low level of a hydrophilic polymer such as a methocel,...
US20130302411 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20130202694 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20120135074 High-Strength Testosterone Undecanoate Compositions  
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods of treatment. In one embodiment, the present...
US20150140092 COATED DRUG DELIVERY FORMULATIONS  
The invention relates generally to methods of making formulations for delivering biological agents to a patient. In one aspect, proliposomal drug-delivery systems for medicaments are provided. In...
US20120027864 COATED DRUG DELIVERY FORMULATIONS  
The invention relates generally to methods of making formulations for delivering biological agents to a patient. In one aspect, proliposomal drug-delivery systems for medicaments are provided. In...
US20120213847 MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA  
The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate...
US20130266642 MALODOR REDUCTION COMPOSITIONS  
The present invention relates to unscented and low scented malodor reduction compositions and methods of making and using same. The malodor reduction compositions are suitable for use in a variety...
US20110244035 Dosage Forms  
Dosage forms comprising therapeutically active compounds are disclosed herein.
US20100062056 ENCAPSULATED PICOPLATIN  
The invention provides an encapsulated unit dosage form for picoplatin that is adapted for oral administration of the picoplatin containing a substantially dry powder with about 20 to 55 wt %...
US20110212169 METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended)  
Disclosed are a method for preparing a powder containing a nanoparticulated sparingly soluble drug, a powder prepared thereby, and a pharmaceutical composition containing the same. The disclosed...
US20150174261 CATIONIC LIPID  
Provided are a cationic lipid which facilitates the introduction of a nucleic acid into, for example, a cell or the like; a composition containing the cationic lipid and a nucleic acid; a method...
US20110081411 Orally Administered Corticosteroid Compositions  
The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the...
US20140358092 Method For Administration Of A Probiotic  
The present invention relates to a method for the administration of a probiotic composition to a vaginal cavity and to compositions, devices and kits for use in this method.
US20150230510 INGESTIBLE NUTRITIONAL DOSE FORMS FOR INDUCING SATIETY  
Ingestible nutritional dose forms are disclosed. The ingestible nutritional dose forms curb appetite, reduce food intake and/or reduce satiety. Methods for making and methods for using the...
US20140348911 SPRAY FORMULATION OF MESENCHYMAL STEM CELLS FOR THE TREATMENT OF CHRONIC WOUNDS  
The present Invention describes therapeutic and medical applications of Mesenchymal Stem Cells, by means of fine mist spraying application system. The mesenchymal stem cells used in the fine mist...
US20140341981 EMULSION STABILIZATION VIA SILICILIC ACID COMPLEXATION  
Disclosed are methods of preparing stable O/W emulsions by silicic acid complexation of micron-sized oil droplets, and stable emulsions prepared by silicic acid complexation. Compositions and...
US20120107393 Pellets for Delivery of Biologically Active Substances  
Pellets are made by combining a direct compression binder and a waxy spheronizing agent. The pellets may further contain additional pharmaceutical ingredients and/or a drug. The pellets may be...
US20140363501 The protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury  
An anti-oxidative Lactobacillus rhamnosus CCFM1107 can relieve chronic alcoholic liver injury, and L. rhamnosus CCFM1107 can be used in preparing dairy products as starter culture. The dairy...
US20140193488 In Situ Antigen-Generating Cancer Vaccine  
The invention provides compositions and methods for utilizing scaffolds in cancer vaccines.
US20140079776 Nanostructures for Drug Delivery  
The present invention provides compositions, preparations, formulations, kits, and methods useful for treating subjects having cancer or at risk of developing cancer. Some embodiments of the...
US20140154308 Microparticle Formulations for Delivery to the Upper and Central Respiratory Tract and Methods of Manufacture  
Microparticle formulations are produced by contacting an aqueous solution of a protein or other active agent with an organic solvent, a counterion and a scavenging agent, and chilling the...